Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2207949
Max Phase: Preclinical
Molecular Formula: C18H10ClN3S
Molecular Weight: 335.82
Molecule Type: Small molecule
Associated Items:
ID: ALA2207949
Max Phase: Preclinical
Molecular Formula: C18H10ClN3S
Molecular Weight: 335.82
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: N#C/C=C1\C=C(c2ccc(Cl)cc2)N=C2Sc3ccccc3N21
Standard InChI: InChI=1S/C18H10ClN3S/c19-13-7-5-12(6-8-13)15-11-14(9-10-20)22-16-3-1-2-4-17(16)23-18(22)21-15/h1-9,11H/b14-9+
Standard InChI Key: JKGAPEFVTREFDL-NTEUORMPSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 335.82 | Molecular Weight (Monoisotopic): 335.0284 | AlogP: 5.07 | #Rotatable Bonds: 1 |
Polar Surface Area: 39.39 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 0 |
#RO5 Violations: 1 | HBA (Lipinski): 3 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: | CX Basic pKa: 2.02 | CX LogP: 4.44 | CX LogD: 4.44 |
Aromatic Rings: 2 | Heavy Atoms: 23 | QED Weighted: 0.68 | Np Likeness Score: -0.86 |
1. Patil VS, Nandre KP, Ghosh S, Rao VJ, Chopade BA, Bhosale SV, Bhosale SV.. (2012) Synthesis and glycosidase inhibitory activity of novel (2-phenyl-4H-benzopyrimedo[2,1-b]-thiazol-4-yliden)acetonitrile derivatives., 22 (23): [PMID:23102653] [10.1016/j.bmcl.2012.10.025] |
Source(1):